IVGTX | RWIBX | IVGTX / RWIBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 1.346 | 2.014 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 127B | 0% |
Annual Yield % from dividends | 0.45 | 1.05 | 43% |
Returns for 1 year | -0.47 | 10.02 | -5% |
Returns for 3 years | -15.00 | 6.90 | -217% |
Returns for 5 years | -9.84 | 24.76 | -40% |
Returns for 10 years | -0.12 | 44.15 | -0% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HEOIX | 16.32 | 0.11 | +0.68% |
Hartford Climate Opportunities I | |||
EEMPX | 7.92 | 0.02 | +0.25% |
MFS Emerging Markets Equity Research A | |||
CTASX | 37.57 | 0.09 | +0.24% |
Calamos Timpani Small Cap Growth A | |||
ETNHX | 33.03 | N/A | N/A |
Eventide Healthcare & Life Sciences N | |||
JFNNX | 67.72 | -0.35 | -0.51% |
Janus Henderson Global Life Sciences N |